August 29, 2011
By Charity Ohlund – Guest Blogger and Devoted Botox Follower
Is there anything Botox can’t do?, but this little wonder drug sure takes care of a lot more than just wrinkles.
On Wednesday, the FDA approved Botox – again. This time it was for the treatment of urinary incontinence. Botox’s growing list of government-approved uses now includes treatments for certain kinds of muscle stiffness and contractions, excessive underarm sweating, abnormal twitch of the eyelid, chronic migraines, crossed eyes and facial wrinkles. I am hoping to hear soon that Botox has been approved for chronic procrastination.
Botox won’t be prescribed to treat the garden variety “leakage” that can occur when sneezing, coughing or jumping rope. This treatment approval is for people who suffer from certain neurological conditions such as multiple sclerosis and spinal cord injury.
Involuntary bladder contractions in patients with these conditions can cause an inability to effectively store urine. The current treatments consist of oral medications to relax the bladder and invasive catheters to regularly empty it. So it’s wonderful that these patients, who already have enough challenges on their plate, will now have an optional treatment for the tricky (not to mention annoying) problem of urinary control.
This new treatment involves injections of Botox directly into the bladder, which causes the muscles to effectively relax and allows the patient more bladder control. The procedure is often performed under general anesthesia while a doctor guides the injections using cytoscopy, which is a very small endoscopic device to visualize the interior of the bladder.
The FDA’s announcement says that two different clinical trials involving 691 patients showed statistically significant decreases in the weekly frequency of incontinence episodes among the Botox group when compared to the group who received a placebo. The effects of the treatment can last up to 10 months.
Allergan Inc., the makers of Botox, must be just rubbing its hands together and hosting TGIF parties for its employees featuring several of those cash grab money blowing booths. Botox sales were already $1.5 billion in 2010. And with more than 100 medical conditions being studied for Botox treatments, the limit to Allergan’s success still seems light years away.
– See more at: https://drkim.com/2011/08/29/fda-approves-botox-to-treat-urinary-incontinence/#sthash.YF4daV27.dpuf